Healthcare Sales & Marketing Network News: Sinusitis

Searching News Database: Sinusitis

HSMN NewsFeed - 31 Jul 2023
Viatris Announces Launch of Breyna(TM) (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort(R) for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 5 Jul 2022
Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 May 2022
Medtronic completes acquisition of Intersect ENT
Devices Mergers & Acquisitions

HSMN NewsFeed - 13 Apr 2022
Lyra Therapeutics Announces Closing of $100.5 Million Private Placement
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Mar 2022
Lyra Therapeutics Appoints Jim Tobin to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jan 2022
Lyra Therapeutics Announces Initiation of LYR-210 Pivotal Phase 3 ENLIGHTEN Program in Surgically Naïve Chronic Rhinosinusitis Patients
Devices Drug Delivery

HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Aug 2021
Medtronic to Acquire Intersect ENT
Devices Mergers & Acquisitions

HSMN NewsFeed - 1 Dec 2020
Novartis announces FDA approval of Xolair(R) (omalizumab) for adults with nasal polyps
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 12 Dec 2019
European Commission Approves EVENITY(R) (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory

HSMN NewsFeed - 18 Oct 2019
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Aug 2019
Dupixent(R) (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory

HSMN NewsFeed - 7 May 2019
Dupixent(R) (dupilumab) Approved for Severe Asthma by European Commission
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Apr 2019
CSL Behring Delivers on its Continued Commitment to Alpha 1 Patients with FDA Approval of Convenient Single-Vial Dosing for ZEMAIRA(R) [Alpha1-Proteinase Inhibitor (Human)]
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 11 Mar 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Mar 2019
CHMP Recommends Approval of Dupixent(R) (dupilumab) for Asthma Indication
Biopharmaceuticals Regulatory

HSMN NewsFeed - 22 Oct 2018
FDA Approves Asthma Indication for Dupixent(R) (dupilumab)
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 6 Dec 2017
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion(R) System
Diagnostics FDA Product Launch

HSMN NewsFeed - 8 Nov 2017
Long-Term Use of Lilly's Taltz(R) (ixekizumab) Shows Efficacy Improvements in Psoriatic Arthritis for Patients with Prior Inadequate Response or Intolerance to TNF Inhibitors
Biopharmaceuticals

HSMN NewsFeed - 5 Oct 2017
Mylan Launches First AP-rated Generic Avelox(R) Injection
Biopharmaceuticals Product Launch

HSMN NewsFeed - 6 Sep 2017
Actelion Receives FDA Approval Of TRACLEER(R) (bosentan) For Use In Pediatric Patients With Pulmonary Arterial Hypertension
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Jan 2017
AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Nov 2016
Aclaris Therapeutics Announces Positive Top-Line Phase 3 Results for A-101 In Treating Seborrheic Keratosis, a Common Undertreated Skin Condition
Biopharmaceuticals Dermatology

HSMN NewsFeed - 17 Aug 2016
ProclaRx Names Doug Martin as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jul 2016
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
Devices Interventional Product Launch

HSMN NewsFeed - 19 Jul 2016
Platinum Diagnostic Lab Announces the Availability of Thermo Scientific ImmunoCAP(TM) Allergy Testing Products
Diagnostics Product Launch

HSMN NewsFeed - 13 Jul 2016
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
Devices FDA

HSMN NewsFeed - 13 Apr 2016
Oculus Innovative Sciences Receives European Approval to Market Sinudox(TM) Indicated for Use in Nasal Irrigation
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Feb 2016
Dr. Reddy’s Laboratories Receives USFDA Tentative Approval for Zenavod(TM) (doxycycline) Capsules, 40 mg for the Treatment of Rosacea in Adults
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 10 Nov 2015
Teva Canada Announces the Launch of PrTeva-Moxifloxacin Tablet, a generic of PrAvelox(R)
Biopharmaceuticals Generics Product Launch

HSMN NewsFeed - 6 Oct 2015
OptiNose Closes New Round of Financing
Devices Drug Delivery Venture Capital

HSMN NewsFeed - 13 Feb 2015
Entellus Medical Announces Release of XprESS(TM) Ultra Multi-Sinus Dilation System
Devices Product Launch

HSMN NewsFeed - 3 Sep 2014
SinuSys Corp. Names Robert Hoxie as Chief Commercial Officer
Devices Personnel

HSMN NewsFeed - 11 Jun 2014
GSK and Theravance Announce Positive Data From Two Studies Evaluating the Efficacy and Safety of Incruse(TM) Ellipta(R) When Added to Relvar(R)/Breo(R) Ellipta(R) in Patients With COPD
Biopharmaceuticals

HSMN NewsFeed - 17 Feb 2014
New Study Affirms In-Office Multi-Sinus Balloon Dilation is an Effective, Well Tolerated Treatment Option for Chronic Sinusitis Sufferers
Devices

HSMN NewsFeed - 8 Jan 2014
Ironwood Pharmaceuticals Announces Alignment of Workforce with Priority Growth Platforms
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 7 Jan 2014
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
Devices FDA

HSMN NewsFeed - 21 Nov 2013
Thomas J. Fogarty, M.D. Joins SinuSys(TM) Corp. Board of Directors
Devices Venture Capital Personnel

HSMN NewsFeed - 11 Nov 2013
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 11 Oct 2013
FDA Files Genentech’s Supplemental Biologics License Application of Xolair(R) (omalizumab) for Chronic Idiopathic Urticaria (CIU)
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 2 Oct 2013
Cook Medical Marks One-Year Anniversary of its Otolaryngology/Head and Neck Surgery Division
Devices Otolaryngology

HSMN NewsFeed - 30 Sep 2013
Entellus Medical & CogENT Therapeutics Announce Distribution Agreement
Devices Distribution

HSMN NewsFeed - 19 Sep 2013
Published Study Demonstrates Benefits of Balloon Sinus Dilation versus Endoscopic Sinus Surgery for Sinusitis Patients
Devices Interventional

HSMN NewsFeed - 11 Sep 2013
Entellus Medical Launches Cordless Trans-illumination Product for Use with the XprESS LoProfile Balloon Multi-Sinus Dilation Device for the Treatment of Sinusitis
Devices Product Launch

HSMN NewsFeed - 26 Aug 2013
Galderma Receives FDA Approval of Mirvaso(R): the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 30 Jul 2013
Edimer Secures $18M Series B Financing Led by New Enterprise Associates
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 25 Jul 2013
Study Shows Benefits of Balloon Sinus Dilation versus Traditional Sinus Surgery for Chronic Sinusitis
Devices

HSMN NewsFeed - 18 Mar 2013
SinuSys Corp. Expands Executive Team
Devices Personnel

HSMN NewsFeed - 25 Feb 2013
Intersect ENT Raises $30 Million
Devices Venture Capital

HSMN NewsFeed - 6 Nov 2012
Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant, Allowing More Chronic Sinusitis Patients to Benefit from Localized Drug Delivery
Devices Drug Delivery

HSMN NewsFeed - 20 Sep 2012
Acton Pharmaceuticals Announces U.S. Food and Drug Administration Approval for AEROSPAN(R) (Flunisolide HFA, 80 mcg) Inhalation Aerosol for Asthma
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Sep 2012
SinuSys Receives CE Mark for AerOs(TM) Sinus DiIation System, Completes FDA 510(k) Submission
Devices Interventional FDA Regulatory

HSMN NewsFeed - 4 Sep 2012
Pfizer Receives EU Marketing Authorization for INLYTA(R) (Axitinib)
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 10 May 2012
SYMBICORT(R) (budesonide/formoterol fumarate dihydrate) Long-Term Study Shows Similar Safety Profile When Compared to Budesonide Monotherapy in African-American Patients with Asthma
Biopharmaceuticals

HSMN NewsFeed - 7 May 2012
New Phase III Data Show Agile Therapeutics' Low-Dose Patch Is Comparable to Combination Oral Contraceptive in a Comparator Study
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 23 Mar 2012
GSK and Theravance Announce Completion of the Relovair(TM)* Registrational Programme and Topline Results From Relovair(TM) vs. Advair(R) Phase III Studies in COPD
Biopharmaceuticals

HSMN NewsFeed - 12 Mar 2012
Organogenesis Inc. Announces FDA Approval of GINTUIT(TM) for Oral Soft Tissue Regeneration
Regenerative Medicine Wound Care FDA

HSMN NewsFeed - 25 Jan 2012
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 9 Jan 2012
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair(TM)* in COPD and Asthma
Biopharmaceuticals

HSMN NewsFeed - 14 Nov 2011
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Oct 2011
Acton Pharmaceuticals, Inc. Announces License Agreement with Sanofi U.S. for NASACORT HFA(TM) (triamcinolone acetonide) Nasal Aerosol
Biopharmaceuticals Licensing

HSMN NewsFeed - 10 Oct 2011
FDA Approves Combivent(R) Respimat(R) (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 23 Sep 2011
Kensey Nash Corporation Announces the Addition of Lisa Earnhardt to its Board of Directors
Devices Regenerative Medicine Personnel

HSMN NewsFeed - 12 Sep 2011
Entellus Medical Launches PathAssistTM Light SeekerTM to Help ENT Physicians Navigate Frontal Sinus Passages
Devices Surgery

HSMN NewsFeed - 8 Jul 2011
Phase III Trial of Novartis Drug Afinitor(R) Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Biopharmaceuticals

HSMN NewsFeed - 28 Apr 2011
Entellus Medical(TM) Study Demonstrates XprESS(TM) Multi-Sinus Dilation Tool Safe and Effective in Treatment of Chronic Sinusitis
Devices

HSMN NewsFeed - 5 Apr 2011
Merck to Acquire Inspire Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 22 Mar 2011
Data Presented at AAAAI Annual Meeting Further Support the Safety and Efficacy of FIRAZYR(R) (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 25 Feb 2011
Medtronic Announces Purchase of Innovative Gel Technology for Potential Use in Functional Endoscopic Sinus Surgery (FESS)
Devices Surgery Acquisitions

HSMN NewsFeed - 23 Feb 2011
Entellus Medical(TM) Receives FDA 510(k) Clearance for FinESS(TM) Endoscope
Devices FDA

HSMN NewsFeed - 3 Nov 2010
Study in NEJM Shows Novartis Drug Afinitor(R) Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Oct 2010
Novartis Drug Afinitor(R) Approved by FDA as First Medication for Children and Adults with a Benign Brain Tumor Associated with Tuberous Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 27 Sep 2010
Acclarent, Inc. Introduces Two New Innovations for Minimally-Invasive Sinus Surgery during AAO - Head and Neck Surgery Conference
Devices Surgery

HSMN NewsFeed - 23 Sep 2010
Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
Biopharmaceuticals Endocrinology Regulatory

HSMN NewsFeed - 24 Jun 2010
FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Jun 2010
Teriflunomide in Adjunct to Interferon Beta Significantly Improved Outcomes of Multiple Sclerosis Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Apr 2010
Entellus Medical(R) Launches the XprESS Multi-Sinus Dilation Tool at COSM 2010 Annual Meeting
Devices

HSMN NewsFeed - 27 Apr 2010
Farley Named President and CEO of Entellus Medical(R)
Devices Personnel

HSMN NewsFeed - 7 Apr 2010
Medtronic Launches New Frontal Handpiece for Its Hydrodebrider System
Devices

HSMN NewsFeed - 2 Mar 2010
New Study Demonstrates Safety of Balloon Sinuplasty(TM) Technology in Pediatric Patients Suffering From Chronic Sinusitis
Devices

HSMN NewsFeed - 5 Feb 2010
Study Suggests Slide-On(R) EndoSheath(R) System Provides Several Advantages over Traditional Germicidal Immersion
Devices

HSMN NewsFeed - 11 Jan 2010
ViroPharma Expands Global Licensing, Commercialization and Development Rights for Cinryze(TM) (C1 esterase inhibitor [human])
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Jan 2010
Acton Pharmaceuticals, Inc. Announces Completion of $15 Million Series A Financing with Sequoia Capital
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 16 Dec 2009
Ethicon Announces Definitive Agreement to Acquire Acclarent
Devices Mergers & Acquisitions

HSMN NewsFeed - 17 Nov 2009
Entellus Medical(R) Secures $30 Million Financing To Expand Commercialization of Novel Treatments for Sinusitis
Devices Venture Capital

HSMN NewsFeed - 19 Oct 2009
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 4 May 2009
Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies
Devices

HSMN NewsFeed - 3 Feb 2009
FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jan 2009
Merck Statement in Response to the FDA's Update Regarding a Safety Review of SINGULAIR® (montelukast)
Biopharmaceuticals

HSMN NewsFeed - 12 Jan 2009
Acclarent, Inc. Closes $26 Million Financing
Devices Venture Capital

HSMN NewsFeed - 8 Jan 2009
FDA Advisory Committee Unanimously Recommends Sabril(R) (vigabatrin) for the Treatment of Two Catastrophic Epilepsies
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 3 Nov 2008
APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Oct 2008
Gilead Announces Two-Year Clinical Data for Letairis(R) (ambrisentan) for the Treatment of Pulmonary Arterial Hypertension (WHO Group 1)
Biopharmaceuticals

HSMN NewsFeed - 21 Oct 2008
ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Sep 2008
New Studies Highlight Benefits of Coblation(R)-Assisted Procedures in Airway Fire Prevention and Endoscopic Sinus Surgery
Devices Surgery

HSMN NewsFeed - 22 Sep 2008
Entellus Medical(R) Launches FinESS(TM) Sinus Treatment at American Academy of Otolaryngology (AAO) Annual Meeting
Devices

HSMN NewsFeed - 22 Sep 2008
New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
Devices

HSMN NewsFeed - 1 Aug 2008
Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla(R) (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries
Biopharmaceuticals HIV/AIDS Distribution

HSMN NewsFeed - 4 Jun 2008
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Biopharmaceuticals FDA

HSMN NewsFeed - 29 May 2008
Data from Pivotal Phase III Studies of Gilead's Letairis(R) (ambrisentan) for Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms Published in Circulation
Biopharmaceuticals

HSMN NewsFeed - 21 May 2008
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 14 May 2008
New Data Support Routine Childhood Vaccination With PREVENAR in Europe
Biopharmaceuticals

HSMN NewsFeed - 6 May 2008
Lev Pharmaceuticals Announces Cinryze(TM) Complete Response Submission Accepted for Review by FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 5 May 2008
Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva(R) in the Treatment of Psoriasis Published in the British Journal of Dermatology
Biopharmaceuticals

HSMN NewsFeed - 2 May 2008
Lev Announces FDA Advisory Committee Unanimously Recommends Approval of Cinryze(TM) for Hereditary Angioedema
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Apr 2008
Accentia Announces that After Reviewing Unblinded Results, Independent DMC Recommends Presenting Data on BiovaxID(R) to FDA and Worldwide Regulatory Agencies in Order to Seek Marketing Approvals for Follicular Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 15 Apr 2008
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Apr 2008
Studies Confirm Balloon Sinuplasty(TM) Helps Chronic Sinusitis Patients
Devices

HSMN NewsFeed - 24 Mar 2008
Accentia Biopharmaceuticals Announces Results on Primary Endpoint in Clinical Study of SinuNase Lavage
Biopharmaceuticals

HSMN NewsFeed - 22 Feb 2008
Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Jan 2008
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
Biopharmaceuticals

HSMN NewsFeed - 28 Jan 2008
Sepracor Acquires Exclusive U.S. Rights to Nycomed's ALVESCO(R) HFA and OMNARIS(TM) AQ Products as Well as Ciclesonide Pipeline
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jan 2008
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jan 2008
ALVESCO(R) Gains FDA Approval for the U.S. Market
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Dec 2007
Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 3 Dec 2007
UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Nov 2007
New Medical Device and Irrigation Solution Exhibits Promising Results in the Removal of Bacterial Colonization in Chronic Sinus Infections
Devices

HSMN NewsFeed - 26 Nov 2007
Carbylan Announces $20 Million Series B Financing
Devices Venture Capital

HSMN NewsFeed - 8 Nov 2007
Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
Biopharmaceuticals

HSMN NewsFeed - 5 Nov 2007
Sepracor Inc. Announces the Establishment of a Unique Product-Specific Billing Code (or J-Code) for BROVANA(R)
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 29 Oct 2007
Gilead Announces 48-Week Data Evaluating Switching from Combivir(R) To Truvada(R) Among Virologically-Suppressed HIV Patients
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 23 Oct 2007
Gilead Announces New LetairisTM (ambrisentan) Data for the Treatment of Patients with Pulmonary Arterial Hypertension (WHO Group 1)
Biopharmaceuticals

HSMN NewsFeed - 18 Oct 2007
European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
Biopharmaceuticals HIV/AIDS Regulatory

HSMN NewsFeed - 17 Oct 2007
Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
Biopharmaceuticals Regulatory HIV/AIDS

HSMN NewsFeed - 16 Oct 2007
Biovest Announces Strategy for Seeking Early Approval of Its Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Oct 2007
Accentia Announces Investigational New Drug Application for Revimmune Usage in a Pivotal Phase 3 Study of Refractory Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Oct 2007
Accentia Biopharmaceuticals Announces Completion of Enrollment in Fast-Tracked Pivotal Phase 3 Clinical Trial of SinuNase for Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2007
Duramed Launches New Indication for ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) at North American Menopause Society Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 27 Sep 2007
Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
Biopharmaceuticals

HSMN NewsFeed - 27 Sep 2007
Critical Therapeutics and Dey Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2007
Critical Therapeutics Highlights Near-Term Milestones to Drive Commercial Success and Clinical Development
Biopharmaceuticals

HSMN NewsFeed - 17 Sep 2007
Vision-Sciences, Inc. Unveils New Video-Based Advanced Endoscopes for Use with its New EndoSheath Technology at World's Largest Gathering of Ear, Nose and Throat Physicians
Devices

HSMN NewsFeed - 17 Sep 2007
FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Biopharmaceuticals Urology FDA

HSMN NewsFeed - 5 Sep 2007
GelStat Strengthens Its Management Team With the Addition of William ("Bill") Colucci as Its President
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Aug 2007
Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Aug 2007
Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 31 Jul 2007
Accentia Biopharmaceuticals Files Pre-Investigational New Drug (IND) Application with FDA for Pivotal Phase 3 Clinical Trial of Revimmune for Refractory Multiple Sclerosis
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 23 Jul 2007
144-Week Data from Gilead's Study 934 Comparing Truvada(R) to Combivir(R) Both in Combination with Sustiva(R) Presented At International AIDS Society Meeting in Sydney
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 16 Jul 2007
Study Confirms Balloon Sinuplasty(TM) Technology is Safe and Effective for Chronic Sinusitis Patients
Devices

HSMN NewsFeed - 10 Jul 2007
Critical Therapeutics Initiates Phase IV Study Evaluating ZYFLO CR(TM) in Asthma Patients on Inhaled Corticosteroids Whose Symptoms Are Poorly Controlled
Biopharmaceuticals

HSMN NewsFeed - 28 Jun 2007
Critical Therapeutics and Dey, L.P. Complete Definitive Co-Promotion Agreement for Perforomist(TM) Inhalation Solution
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 26 Jun 2007
Critical Therapeutics' Zileuton Provides Additional Asthma Control When Combined with Inhaled Corticosteroids
Biopharmaceuticals

HSMN NewsFeed - 25 Jun 2007
Naryx Pharma, Inc. Announces the Appointment of Andy H. Strayer, Pharm.D. as Vice President of Clinical Operations and Medical Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jun 2007
AstraZeneca Announces SYMBICORT(R) is Now Available in the U.S.
Biopharmaceuticals

HSMN NewsFeed - 15 Jun 2007
U.S. Food and Drug Administration Approves Gilead's Letairis(TM) (ambrisentan) 5 mg and 10 mg Tablets for the Once-Daily Treatment of Pulmonary Arterial Hypertension (WHO Group 1) in Patients with WHO Functional Class II or III Symptoms
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jun 2007
Critical Therapeutics Announces the Publication of Data for ZYFLO CR(TM) (Zileuton) Extended-Release Tablets in the Journal of Asthma
Biopharmaceuticals

HSMN NewsFeed - 5 Jun 2007
Biovest to File for Accelerated Conditional Approval of BiovaxID
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 31 May 2007
FDA Approves Critical Therapeutics' Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for Asthma
Biopharmaceuticals FDA

HSMN NewsFeed - 22 May 2007
New Analysis of Data Shows Treatment With Abbott's HUMIRA(R) (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 22 May 2007
Advancis Pharmaceutical Announces FDA Acceptance of Amoxicillin PULSYS NDA
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 21 May 2007
New Study Demonstrates That Lubiprostone May Improve Symptom Relief Rates in Adults With Irritable Bowel Syndrome With Constipation (IBS-C)
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 May 2007
Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin in Complicated Urinary Tract Infections and Acute Pyelonephritis
Biopharmaceuticals Urology

HSMN NewsFeed - 14 May 2007
Accentia Biopharmaceuticals Makes Milestone Payment Based on Fast Tracked Pivotal Phase 3 Study with SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals

HSMN NewsFeed - 7 May 2007
Abbott Seeks U.S. and E.U. Regulatory Approvals for HUMIRA(R) (Adalimumab) as a Treatment for Juvenile Rheumatoid Arthritis
Biopharmaceuticals FDA Regulatory

HSMN NewsFeed - 1 May 2007
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Apr 2007
New Medical Device and Irrigation Solution Exhibits Promising Results in the Removal of Bacterial Colonization in Chronic Sinus and Ear Infections
Devices

HSMN NewsFeed - 30 Apr 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Apr 2007
FDA Approves Fast Track Designation for Naryx Pharma's Product for Chronic Sinusitis
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Apr 2007
BROVANA(TM) Inhalation Solution Now Available by Prescription for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2007
Abbott Opens New Biotechnology Manufacturing Facility in Puerto Rico
Biopharmaceuticals

HSMN NewsFeed - 2 Apr 2007
Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 23 Mar 2007
Advancis Pharmaceutical Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
Biopharmaceuticals

HSMN NewsFeed - 28 Feb 2007
Advancis Pharmaceutical Reaches Agreement with FDA for Resubmission of Amoxicillin PULSYS NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Feb 2007
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 26 Feb 2007
Takeda and TAP to Promote Sucampo's AMITIZA(R) in the United States
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 16 Feb 2007
Merck & Co., Inc. (1) To Distribute ATRIPLA(TM) in Developing Countries
Biopharmacetuicals HIV/AIDS

HSMN NewsFeed - 12 Feb 2007
sanofi-aventis Announces Update to U.S. Prescribing Information for Ketek(R) (Telithromycin)
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2007
Psoriasis Patients Show Significant Improvement in Symptoms with Abbott's HUMIRA(R) in New Phase III Study
Biopharmaceuticals Dermatology

HSMN NewsFeed - 29 Jan 2007
FDA Approves New Indication for YAZ(R) to Treat Acne
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 26 Dec 2006
Faropenem Phase III Clinical Trial Stopped to Consider Exclusion of Ketek Comparator
Biopharmaceuticals

HSMN NewsFeed - 21 Dec 2006
Accentia Biopharmaceuticals in Discussions with Pharmaceutical Companies on SinuNase Partnership
Biopharmaceuticals

HSMN NewsFeed - 14 Dec 2006
Ranbaxy Is Granted Final Approval to Manufacture and Market Cefprozil Anti- Infective Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 12 Dec 2006
Valeant Pharmaceuticals Initiates Infergen(R) Phase 4 Study
Biopharmaceuticals

HSMN NewsFeed - 22 Nov 2006
OctoPlus Grants Green Cross Corporation Exclusive Korean License to OP-145 for Chronic Middle ear Infection
Biopharmaceuticals Licensing

HSMN NewsFeed - 14 Nov 2006
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients With Psoriatic Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Nov 2006
ORENCIA(R) (abatacept) Data Demonstrated Improvement in Children and Adolescents With Juvenile Idiopathic Arthritis as Measured by the Validated ACR Pediatric Criteria
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Interim Analysis of New Study Suggests Boosted INVIRASE(R) May Achieve Similar Levels of HIV Suppression to Boosted Lopinavir with a Favorable Lipid Profile
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 7 Nov 2006
Naryx Pharma, Inc. Announces the Election of Geron Corporation Executive Alan B. Colowick to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Nov 2006
Accentia Biopharmaceuticals Commences Fast-Tracked Phase 3 Clinical Trial of SinuNase for the Treatment of Chronic Sinusitis
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Oct 2006
Valeant Pharmaceuticals Presents End-of-Treatment Results of DIRECT Trial for Infergen at the American Association for the Study of Liver Diseases 2006 Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 26 Oct 2006
Abbott's HUMIRA(R) (Adalimumab) Granted FDA Priority Review for the Treatment of Moderately to Severely Active Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 23 Oct 2006
New Phase III Data Shows Abbott's HUMIRA(R) (Adalimumab) Induced Clinical Remission In Patients With Crohn's Disease Who Lost Response to, or Were Intolerant to, Remicade(R) (Infliximab)
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 23 Oct 2006
AMITIZA(TM) (lubiprostone) Phase III Constipation Trial Results Demonstrate Improvements in Symptoms of Irritable Bowel Syndrome With Constipation
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 23 Oct 2006
BROVANA(TM) (Arformoterol Tartrate) Inhalation Solution Study Data Presented at American College of Chest Physicians Annual Conference
Biopharmaceuticals

HSMN NewsFeed - 23 Oct 2006
U.S. Food and Drug Administration Issues Non-Approvable Letter for Faropenem
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Oct 2006
New Landmark Study Shows the Use of a BiovaxID Formulation Improves Disease Free survival in 80% of Patients Whose Cancer has Relapsed after Chemotherapy Administered With or Without Rituxan
Biopharmaceuticals Oncology

HSMN NewsFeed - 9 Oct 2006
GlaxoSmithKline to Acquire CNS, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Oct 2006
Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit Marketing Authorisation Application for ATRIPLA(TM) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) to European Medicines Agency
Biopharmaceuticals Regulatory HIV/AIDS

HSMN NewsFeed - 7 Oct 2006
FDA Approves Sepracor's BROVANA(TM) (Arformoterol Tartrate) Inhalation Solution for Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Oct 2006
Oscient Pharmaceuticals and Pfizer, S.A. de C.V. Announce Launch of FACTIVE(R) Tablets in Mexico
Biopharmaceuticals

HSMN NewsFeed - 4 Oct 2006
Auriga Executes Agreement Naming River's Edge Pharmaceuticals as Authorized Generic Distributor of Extendryl and Levall
Biopharmaceuticals Distribution Generics

HSMN NewsFeed - 29 Sep 2006
Efficacy of Once-Daily AVELOX(R) in Treating Complicated Intra-Abdominal Infections Highlighted in Two Clinical Data Presentations at ICAAC
Biopharmaceuticals

HSMN NewsFeed - 19 Sep 2006
Multi-Center Study Confirms Balloon Sinuplasty(TM) Technology Is Safe and Effective
Devices Otolaryngology

HSMN NewsFeed - 13 Sep 2006
Oscient Pharmaceuticals Announces Results of FDA Advisory Committee Meeting for FACTIVE Tablets for the Treatment of Acute Bacterial Sinusitis
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Sep 2006
Advancis Pharmaceutical On Track to File NDA for Amoxicillin PULSYS
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Sep 2006
Abbott Submits U.S. and E.U. Regulatory Applications Seeking Approval for HUMIRA(R) (Adalimumab) as a Treatment for Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 30 Jun 2006
Ranbaxy Receives Approval to Market Cefprozil Suspension
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 29 Jun 2006
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
Biopharmaceuticals FDA

HSMN NewsFeed - 28 Jun 2006
Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory Committee to Address sNDA for Five-Day Treatment of Acute Bacterial Sinusitis with FACTIVE Tablets
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Jun 2006
Abbott Receives FDA Approval for New HUMIRA(R) Delivery Device
Biopharmaceuticals FDA Drug Delivery

HSMN NewsFeed - 1 Jun 2006
Advancis Pharmaceutical Completes Enrollment in Amoxicillin PULSYS Phase III Trial
Biopharmaceuticals

HSMN NewsFeed - 24 May 2006
Association Between Molecular Remission and Disease-Free Survival in Non-Hodgkins Lymphoma at Over Nine Years Follow-Up To Be Presented
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2006
Promising Pivotal Phase III Data Show Abbott's Humira(R) (Adalimumab) Maintained Clinical Remission in Patients With Crohn's Disease Through One Year
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 21 May 2006
New Study Demonstrates That AMITIZA(TM) (lubiprostone) May Help Improve Symptoms of Irritable Bowel Syndrome With Constipation
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 21 May 2006
AMITIZA(TM) (Lubiprostone) Shown Effective and Well-Tolerated in People Older than Age 65, a Population Considerably Affected by Chronic Idiopathic Constipation
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 16 May 2006
FDA Gives Permission to Use Very Sensitive Molecular Evidence of Cancer in BiovaxID Pivotal Phase 3 Clinical Trial
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 11 May 2006
FDA Grants Accentia Biopharmaceuticals, Inc.'s Majority-Owned Subsidiary Fast Track Status for BiovaxID(TM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 10 May 2006
Biovest's AutovaxID(TM) Cleared for Commercial Sale
Biopharmaceuticals Devices FDA

HSMN NewsFeed - 8 May 2006
Accentia Biopharmaceuticals Receives FDA Approval for Three Unique Dosage Combination Pain Product ANDAs
Biopharmaceuticals FDA

Return to NewsFeed

Additional items found! 151

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 151 additional stories matching:
Sinusitis
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.